RADIOMEDIX
Company Overview
Industries
Social Media Profiles
About RadioMedix
Description
RadioMedix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and treatment. The company focuses on developing innovative radiopharmaceuticals for PET imaging and therapeutic applications, utilizing both alpha and beta labeling techniques.
Specialties
Targeted radiopharmaceuticals
PET imaging development
Alpha and beta-labeled therapies
Clinical trial manufacturing
Molecular imaging for pre-clinical evaluation
Products & Services
Targeted Radiopharmaceuticals
PET Imaging Agents
Alpha-labeled Therapeutics
Beta-labeled Therapeutics
cGMP Manufacturing Services
Contact Information
No contact information available
Competitors & Similar Companies(8)
Novartis
Basel-City, • Switzerland
Bristol-Myers Squibb
New York, • United States
Pfizer
New York, • United States
Amgen
California, • United States
AstraZeneca
Greater London, • United Kingdom
Seattle Genetics
Siemens Healthineers
CuraLeaf
Massachusetts, • United States
News & Media
Search Terms:
radiomedix
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about RadioMedix
Where is RadioMedix located?
The headquarter of RadioMedix is located in Houston, Texas, United States
What is the official website of RadioMedix?
The official website of RadioMedix is https://www.radiomedix.com
What industry does RadioMedix belong to?
RadioMedix belongs to the Biotechnology, Pharmaceuticals, Pharmaceuticals and Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of RadioMedix?
RadioMedix specializes in Targeted radiopharmaceuticals, PET imaging development, Alpha and beta-labeled therapies, Clinical trial manufacturing, Molecular imaging for pre-clinical evaluation.
What products and services is RadioMedix likely to offer?
RadioMedix offers Targeted Radiopharmaceuticals, PET Imaging Agents, Alpha-labeled Therapeutics, Beta-labeled Therapeutics, cGMP Manufacturing Services.
Who are the competitors of RadioMedix?
Competitors of RadioMedix are Novartis, Bristol-Myers Squibb, Pfizer, Amgen, AstraZeneca, Seattle Genetics, Siemens Healthineers, CuraLeaf.
What does RadioMedix do?
RadioMedix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and treatment. The company focuses on developing innovative radiopharmaceuticals for PET imaging and therapeutic applications, utilizing both alpha and beta labeling techniques.